This page has been fact checked by an experienced mesothelioma Patient Advocate. Sources of information are listed at the bottom of the article.
We make every attempt to keep our information accurate and up-to-date.
Please Contact Us with any questions or comments.
Dr. Vinicius Ernani is a thoracic medical oncologist specializing in thoracic malignancies, including malignant pleural mesothelioma, lung cancer, and thymic cancers. He provides clinical care and develops and co-chairs clinical trials in lung cancer at the Mayo Clinic in Phoenix, Arizona. He is board-certified by the American Board of Internal Medicine in both Medical Oncology and Hematology.
Education and Career
Dr. Ernani is originally from Lages-Santa Catarina Brazil, and he earned his medical degree at the Pontificia Universidade Catolica do Rio Grande do Sul, in Porto Alegre, Brazil. From there he completed an Internal Medicine residency at Jackson Memorial Hospital/University of Miami, then completed a Hematology/Oncology fellowship at the Winship Cancer Institute of Emory University in Atlanta, Georgia.
Dr. Ernani attributes his passion for treating lung cancer patients to the “superb role models and mentorship within the thoracic department” that he received during his fellowship at Emory University. After his fellowship, he served as an assistant professor at the Fred and Pamela Buffett Cancer Center of the University of Nebraska and was an active member of the National Comprehensive Cancer Network (NCCN) guidelines. Today he treats patients as a member of both the Oncology department and Hematology department at the Mayo Clinic in Phoenix, Arizona.
Dr. Ernani is actively involved in developing and co-chairing clinical trials for the treatment of lung cancer and malignant pleural mesothelioma. His research includes a Phase 2 randomized trial of adjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma and a pilot study of first-line Tumor Treating Fields for advanced or metastatic non-small cell lung cancer.
Dr. Ernani is a member of the Lung Cancer Disease Group Committee of Academic and Community Cancer Research United (ACCRU) and was previously a member of the Data Safety and Mentoring Committee (DSMC) at the University of Nebraska. He is also a member of the Career Development and Fellowship Committee of the International Association for the Study of Lung Cancer (IASLC) and of the American Society of Clinical Oncology (ASCO).Get Your FREE Mesothelioma Packet
Written by Terri Oppenheimer
Terri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Page Edited by Patient Advocate Dave Foster
Dave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.